Skip to main content
MedPathMedPath Home
Clinical Trials/ISRCTN45347268
ISRCTN45347268
Completed
Not Applicable

Prevention of post-operative atrial fibrillation: pathophysyological characterisation of a pharmacological intervention based on a novel model of non-hypoxic pre-conditioning

Fondo de Desarrollo Científico y Tecnológico (Chile)0 sites150 target enrollmentSeptember 2, 2009
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsPost-operative atrial fibrillationCirculatory SystemAtrial fibrillation and flutter

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Post-operative atrial fibrillation
Sponsor
Fondo de Desarrollo Científico y Tecnológico (Chile)
Enrollment
150
Status
Completed
Last Updated
11 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 2, 2009
End Date
TBD
Last Updated
11 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Fondo de Desarrollo Científico y Tecnológico (Chile)

Eligibility Criteria

Inclusion Criteria

  • •1\. Aged between 30 \- 80 years, either sex
  • •2\. Scheduled for elective coronary artery bypass graft, valve surgery, or mixed
  • •3\. In sinus rhythm

Exclusion Criteria

  • •1\. Previous heart surgery
  • •2\. Pre\-operative documented history of chronic or paroxysmal AF
  • •3\. Comorbidities such as congenital or cardiac re\-operation
  • •4\. Advanced hepatic disease (cirrhosis)
  • •5\. Chronic renal failure (serum creatinine greater than 2\.0 mg/dL)

Outcomes

Primary Outcomes

Not specified

Similar Trials

Active, not recruiting
Phase 1
Prevention of post-operative Atrial Fibrillation by BOTulinum toxin injections into epicardial fat pads around pulmonary veins in patients undergoing cardiac surgery
EUCTR2018-002541-11-FRASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)220
Completed
Not Applicable
Prevention of Postoperative Atrial Fibrillation after Heart Valve Surgery by L-Carnitine: Study Protocol for An Observational Intervention StudyHeart valve diseases
JPRN-UMIN000025737Hokkaido University Hospital; Department of Cardiovascular and Thoracic Surgery16
Recruiting
Phase 2
PPOAFVALVEtrialHeart valve diseaseD006349
JPRN-jRCTs011190012Shingu Yasushige145
Recruiting
Phase 3
Prevention Atrial Fibrillation by BOTulinum Toxin Injections (BOTAF)Cardiac Surgery
NCT04075981Assistance Publique - Hôpitaux de Paris220
Not yet recruiting
Not Applicable
Post operative occurrence of atrial fibrillation and risk factor analysis among patients undergoing coronary artery bypass grafting in a tertiary care hospital.Health Condition 1: I708- Atherosclerosis of other arteries
CTRI/2023/05/052175Dr Pallavi Mishra